+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Kaempferol 3-O-gentiobioside

BP3219
22149-35-5
98%
Phytounique
1. Kaempferol activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndrome. 2. Kaempferol exerts a potent inhibitory effect on in vitro bone resorption. 3. Kaempferol has anti-inflammatory action, can prevent and treat inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis. 4. Kaempferol has therapeutic potential for the prevention and treatment of thrombovascular diseases, can enhance relaxations caused by endothelium-derived and exogenous NO as well as those due to endothelium-dependent hyperpolarization. 5. Kaempferol can inhibit cancer cell invasion through blocking the PKCδ/MAPK/AP-1 cascade and subsequent MMP-9 expression and its activity, may act as a therapeutic potential candidate for cancer metastasis. 6. Kaempferol is an autophagic enhancer, has a more general protection in Parkinson's disease, can mediate antiapoptotic and antioxidant effects is the enhancement of mitochondrial turnover by autophagy. Kaempferol 3-beta-gentiobioside is a kaempferol O-glucoside in which the hydroxy hydrogen at position 3 of kaempferol has been replaced by a gentiobiosyl group. It has a role as a Brassica napus metabolite. It is a trihydroxyflavone, a disaccharide derivative and a kaempferol O-glucoside. It is functionally related to a gentiobiose.
Catalog No Package Original Price Price Inventory Quantity Operating
BP3219-10mg 10mg
BP3219-20mg 20mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

PTPN1 NFE2L2 SLC5A2 TNF NOS2 PPARG PTGS2 AKT1 DPP4 IL6 HMOX1 MTOR
PTPN1 NFE2L2 TNF NOS2 PPARG MMP9 PTGS2 AKT1 IL6 HMOX1 MTOR
NFE2L2 PPARG AKT1 HMOX1

Product drug property prediction parameters

  • 269.4300

  • -.9562

  • -1.0493

  • 3.2494

  • .3878

  • .1200

  • Low

  • 75.3697

  • 4.6897

  • Yes

  • No

  • No

  • No

  • Yes

  • No

  • 1.2

  • Yes

  • Yes

  • Yes

  • Yes